AU5382200A - Muc1 ligands - Google Patents
Muc1 ligandsInfo
- Publication number
- AU5382200A AU5382200A AU53822/00A AU5382200A AU5382200A AU 5382200 A AU5382200 A AU 5382200A AU 53822/00 A AU53822/00 A AU 53822/00A AU 5382200 A AU5382200 A AU 5382200A AU 5382200 A AU5382200 A AU 5382200A
- Authority
- AU
- Australia
- Prior art keywords
- muc1
- ligands
- muc1 ligands
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13926399P | 1999-06-15 | 1999-06-15 | |
US60139263 | 1999-06-15 | ||
PCT/CA2000/000711 WO2000077031A2 (en) | 1999-06-15 | 2000-06-15 | Muc1 ligands |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5382200A true AU5382200A (en) | 2001-01-02 |
Family
ID=22485831
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU53822/00A Abandoned AU5382200A (en) | 1999-06-15 | 2000-06-15 | Muc1 ligands |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU5382200A (en) |
WO (1) | WO2000077031A2 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2452445C (en) * | 2000-06-29 | 2011-02-15 | North Shore-Long Island Jewish Health System | Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof |
AU2002246791C1 (en) | 2000-12-22 | 2008-04-03 | Dana-Farber Cancer Institute, Inc. | Regulation of cell growth by MUC1 |
WO2002090373A1 (en) * | 2001-05-04 | 2002-11-14 | The Uab Research Foundation | Human sperm activator peptides |
EP2116248A1 (en) | 2001-09-05 | 2009-11-11 | Minerva Biotechnologies Corporation | Compositions and Methods of Treatment of Cancer |
WO2005042573A1 (en) | 2003-10-24 | 2005-05-12 | Dana-Farber Cancer Institute, Inc. | Modulation of the interaction of muc1 with muc1 ligands |
JP5068174B2 (en) * | 2004-12-23 | 2012-11-07 | カンピナ ネーデルランド ホールディング ビー.ブイ. | Protein hydrolyzate concentrated in peptides inhibiting DPP-IV and uses thereof |
EP1954299B1 (en) | 2005-11-30 | 2016-01-13 | Campina Nederland Holding B.V. | Use of a protein hydrolysate for enhancing activity of glucagon-like peptide-1 |
WO2008097844A2 (en) | 2007-02-02 | 2008-08-14 | Dana -Farber Cancer Institute, Inc. | Methods and compositions relating to the regulation of apoptosis by muc1 and bh3- containing proapoptotic proteins |
US7972870B2 (en) | 2007-02-02 | 2011-07-05 | Dana-Farber Cancer Institute, Inc. | Methods and compositions relating to the regulation of MUC1 by HSF1 and STAT3 |
US10344052B2 (en) * | 2013-03-14 | 2019-07-09 | Health Research, Inc. | Targeting peptides and uses thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9108652D0 (en) * | 1991-04-23 | 1991-06-12 | Antisoma Ltd | Immunoreactive compounds |
ATE217344T1 (en) * | 1994-09-21 | 2002-05-15 | Cytogen Corp | ANTIGEN BINDING PEPTIDES (ABTIDES) FROM PEPTIDE LIBRARIES |
AUPN568095A0 (en) * | 1995-09-27 | 1995-10-26 | Austin Research Institute, The | Anti-Galalpha(1,3)Gal antibody binding peptides |
-
2000
- 2000-06-15 WO PCT/CA2000/000711 patent/WO2000077031A2/en active Application Filing
- 2000-06-15 AU AU53822/00A patent/AU5382200A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2000077031A2 (en) | 2000-12-21 |
WO2000077031A3 (en) | 2001-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1173201A (en) | Skin-gripper | |
AU3092999A (en) | Digital-timeshare-exchange | |
AU5967600A (en) | Candystraw | |
AU7514700A (en) | Cyanopiperidines | |
AU4115400A (en) | Short-circuiter | |
AU6335000A (en) | Depthimeter | |
AU5382200A (en) | Muc1 ligands | |
AU2023701A (en) | Sketcher | |
AU6440900A (en) | Homogentisate-dioxygenase | |
AU2804600A (en) | Arylaminoalkylamides | |
AU2699800A (en) | Organoceramics | |
AU4916900A (en) | Benzofuranylsulfonates | |
AU6098300A (en) | Follistatin-3 | |
AU3191100A (en) | Ligand-bonded complex | |
AU4561600A (en) | Benzofuranylaminoalcohols | |
AU1901801A (en) | Glucofuranoses | |
AU1915601A (en) | Periotome | |
AU2582200A (en) | Windturbine | |
AU7513400A (en) | Hydantoin-racemase | |
AU4435300A (en) | Hula-hoop | |
AU7303400A (en) | Osseo-distractor | |
AU5416100A (en) | Retinoscopes | |
AU2197301A (en) | Microlamp | |
AU7567500A (en) | Duckboard | |
AU1737601A (en) | Collectalbum |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |